Learn more

SYNAPSE BV

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    215,954
  • Filing trend
    ⇩ 100.0%
About

SYNAPSE BV has a total of 36 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are BIOVATOR TECHNOLOGIES AB, SIENNA CANCER DIAGNOSTICS LTD and RETI MARK CO LTD.

Patent filings per year

Chart showing SYNAPSE BVs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Hemker Hendrik Coenraad 22
#2 Giesen Peter 11
#3 Wagenvoord Robert 11
#4 Beguin Suzette 7
#5 Nijhuis Sebastiaan 6
#6 Apitz-Castro Rafael Jesus 6
#7 Al-Dieri Raed 6
#8 Ramjee Manoj 4
#9 Beguin Suzette L 4
#10 Hemker Hendrick C 4

Latest patents

Publication Filing date Title
EP3363912A1 Self-calibrated assay for determining proteolytic enzyme generation, dedicated means and uses thereof
EP2789631A1 Compounds and methods for inhibition of binding of ICAM-4 to platelet integrin alphaIIbbeta3
WO2013028069A1 Thermostable inhibitors of activation of the blood clotting system through contact with foreign surfaces.
EP2677037A1 Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood
EP2313785A1 A method and assembly for measuring thrombin generation in plasma
EP2088435A1 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate
EP1717588A1 Measuring thrombin activity in whole blood
AU2003232720A1 Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media
US6740496B1 Determination of biologically active forms of proteolytic enzymes
EP1159448A1 Determination of biologically active forms of proteolytic enzymes